Subharekha Raghavan

Statistics

Publications

Citations

886

H-Index

Active since

1993

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Kettering University

Columbia University

Arena Pharmaceuticals (United States)

United States Military Academy

Subharekha Raghavan is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicinal chemistry, pharmacology, and drug discovery.

Publications per year

1993–2010

Publications

A one step synthesis of the ciclamycin trisaccharide

Subharekha Raghavan, Daniel Kahne · Journal of the American Chemical Society · 1993 · 255 citations

Pharmacy, Chemistry, Drug Design +5

First Total Synthesis of Staurosporine and ent-Staurosporine

J. T. Link, Subharekha Raghavan, Samuel J. Danishefsky · Journal of the American Chemical Society · 1995 · 141 citations

Natural Sciences, Biochemistry, Chemistry +8

Staurosporine and <i>ent</i>-Staurosporine: The First Total Syntheses, Prospects for a Regioselective Approach, and Activity Profiles<sup>1</sup>

J. T. Link, Subharekha Raghavan, Michel Gallant et al. · Journal of the American Chemical Society · 1996 · 133 citations

Life Sciences, Biochemistry, Chemistry +17

Scavenging Byproducts in the Sulfoxide Glycosylation Reaction: Application to the Synthesis of Ciclamycin 0

Jeffrey C. Gildersleeve, A. Lee Smith, Kaori Sakurai et al. · Journal of the American Chemical Society · 1999 · 95 citations

Pharmacy, Biochemistry, Medicinal Chemistry +17

Discovery of a Biaryl Cyclohexene Carboxylic Acid (MK-6892): A Potent and Selective High Affinity Niacin Receptor Full Agonist with Reduced Flushing Profiles in Animals as a Preclinical Candidate

Hong C. Shen, Fa‐Xiang Ding, Subharekha Raghavan et al. · Journal of Medicinal Chemistry · 2010 · 59 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +12

1–5 of 16